Because advanced ccRCC display both aberrant metabolism and elevated immune infiltration, we investigated whether intrinsic IFNγ signaling and PD-L1 could affect the metabolism of ccRCC. This evidence concerns the gene CD274 and nonpapillary renal cell carcinoma.